MEHMET U.S. AYVACI


  • Main           CV 
  •  
  •         Research            News           Teaching





  • My areas of research broadly focus on clinical applications of decision theory and economics of health information sharing. In particular, I study 1) decisions related to cancer diagnosis/treatment and kidney transplantation for micro-level medical decisions and their macro-level impact on health policy, 2) economics of health information exchanges (HIE) in relation to payment systems and their effect on hospital operations. Because of the interdisciplinary nature of my work, I also have publications in clinical and medical-informatics journals on the broader subjects of cost-effectiveness, comparative effectiveness, and analytics in healthcare. Below, I provide a brief list of my most recent work.  Please check my CV for more detail. 


    Clinical Applications of Decision Theory  
    • The Effect of Budgetary Restrictions on Breast Cancer Diagnostic Decisions. Ayvaci MUS, Alagoz O, Burnside ES. Manufacturing & Service Operations Management. 2012 - Articles In Advance.
    • The Role of Patient Preferences in Optimally Managing Post-Mammography Diagnostic Decisions. Ayvaci MUS, Alagoz O, Burnside E.
    • The Profiling Conundrum in Biopsy Decisions Based on Mammography: Does Profile Information Benefit or Hurt? Ayvaci MUS, Ahsen ME, Raghunathan S, Gharibi Z. (See news for the publicity of this work)
    • Optimal Use of Multiple Sources of Information Under Anchoring Bias: An Application to Judgments on Breast Imaging. Ahsen E, Raghunathan S, Ayvaci MUS.
    Economics of Healthcare and Health Information Sharing
    • Does Health Information Exchange Move Patients Through Emergency Departments Faster? With Ayer T, Karaca Z, Vlachy J, Wong H.
    • Health Information Exchange Adoption in the Face of Payment Reform. With Cavusoglu H, Raghunathan S.
    • To Bundle or not To Bundle: Optimal Operations Planning and Cost Accounting for Hospitals'' 
      With Ayer T, Vlachy J. 

    Comparative/Cost Effectiveness in Healthcare

    • Cost-Effectiveness of Adjuvant FOLFOX and LV5FU2 Chemotherapy for Patients with Stage II Colon Cancer. Ayvaci MUS, Shi K, Alagoz O, Lubner S. Medical Decision Making. 33 (4), p.521-532, 2013.
    • Comparative Effectiveness Analysis of Induction Therapy in Live Donor Kidney Transplantation. Tanriover B, Zhang S,
      Gao A, Sandikci B, Ayvaci MUS, Mete M, Tsapepas D, Rajora N, Mohan P, Lakhia R, Lu C, Vazquez M (Conditionally Accepted to CJASN)
    • Cost-Effectiveness Analysis of Immunosuppression Therapy in Primary Deceased Donor Renal Transplantation. Gharibi Z, Ayvaci MUS, Hahsler M, Tanriover B. (Working Paper)
    Analytics in Healthcare